Amifostine and chemoradiation therapy: ASCO responds Journal Article
| Authors: | Schuchter, L.; Meropol, N. J.; Winer, E. P.; Hensley, M. L.; Somerfield, M. R. |
| Article Title: | Amifostine and chemoradiation therapy: ASCO responds |
| Keywords: | cancer survival; clinical trial; drug efficacy; risk benefit analysis; note; combined modality therapy; clinical practice; medical decision making; mucosa inflammation; radiotherapy; practice guideline; cytotoxicity; oncology; hypotension; head and neck cancer; medical society; xerostomia; nausea and vomiting; mouth mucosa; amifostine; drug use; practice guidelines; humans; human; priority journal |
| Journal Title: | Lancet Oncology |
| Volume: | 4 |
| Issue: | 10 |
| ISSN: | 1470-2045 |
| Publisher: | Elsevier Science, Inc. |
| Date Published: | 2003-10-01 |
| Start Page: | 593 |
| Language: | English |
| DOI: | 10.1016/s1470-2045(03)01216-6 |
| PUBMED: | 14554234 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Export Date: 25 September 2014 -- Source: Scopus |
